|

6 months treatment with a single antiplatelet agent Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Pipeline

Phase 4: 1

Top Sponsors

  • National Institute of Cardiology, Warsaw, Poland1

Indications

Other1 trial

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.